MEG3 and neuroblastoma: In the four normal control samples, 32% of IG-DMR CpGs sequenced were methylated, while in the SK-N-AS neuroblastoma cell line with GTL2 promoter DMR hypermethylation, all eight CpGs (n=12 clones) were methylated.